Experience of Using Genetically Engineered Insulin Preparations Produced by Farmak Company in Patients with Diabetes Mellitus Type 2

Abstract

The article deals with one of the most urgent and important socio-economic problems of clinical endocrinology — diabetes mellitus (DM). With the progression of DM, it is harder to control the disease; in this regard, insulin provides additional benefits. The findings of the study on the long-term efficacy and tolerability of all types of Farmasulin preparations in patients with diabetes mellitus type 2 are provided.

Keywords

• diabetes mellitus
• insulin therapy
• Farmasulin